EU vs UTHR · rev $13.4M vs P/E 20, rev $2.88B
enCore Energy Corp. Common Shares (EU) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
enCore Energy Corp. Common Shares (EU) is a uranium company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported EU revenue for 2024-12-31 was $13.4M. Net income was -$17.1M. Revenue was up 44.3% from 2024-09-30 to 2024-12-31. EU currently screens at market cap $268.0M.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
EU currently screens at market cap $268.0M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the EU and UTHR stock pages for the full models.
Not investment advice.